Pancreatic cancer & tumours — expert surgery, explained honestly

The pancreas is a gland tucked behind the stomach that produces digestive enzymes and insulin. When abnormal cells grow within it, the result is a spectrum of diseases — some aggressive, some slow-growing, some curable. The most important types are:

• Pancreatic adenocarcinoma — the most common type, arising from the ductal cells; requires urgent surgical assessment.
• Neuroendocrine tumours (NETs) — often slower-growing; many are surgically curable even at a later stage.
• Cystic tumours (IPMN, MCN) — fluid-filled sacs that can progress to cancer; careful surveillance and timely surgery prevent malignant transformation.
• Periampullary tumours — cancers arising at or near the junction of the bile duct, pancreatic duct, and duodenum; prognosis is often better than pancreatic adenocarcinoma.

The location of the tumour within the pancreas — head, body, or tail — determines the operation needed. A thorough staging work-up establishes what is possible before any decision is made.

Pancreatic cancer can be silent in its early stages. When symptoms appear, prompt assessment matters. See a specialist if you notice:

• Painless jaundice — yellow eyes or skin, dark urine, pale stools (a tumour in the head of the pancreas blocking the bile duct)
• Unexplained weight loss — significant, rapid loss without dieting
• Upper-abdominal or back pain — a deep, persistent ache that may be worse lying down
• New-onset diabetes — especially in those over 50 with no other risk factors
• Loss of appetite and fatigue — persistent and unrelated to another cause

None of these symptoms is specific to pancreatic cancer — but each one warrants prompt evaluation. If a tumour is present, earlier assessment means more surgical options.

No single cause triggers pancreatic cancer, but several factors increase risk:

• Smoking — the single most modifiable risk factor
• Chronic pancreatitis — longstanding inflammation raises lifetime cancer risk
• Family history — first-degree relatives with pancreatic cancer or BRCA mutations
• Long-standing diabetes — particularly when poorly controlled over many years
• Obesity and sedentary lifestyle
• Age — most cases occur after 60, though younger presentations do occur

Having a risk factor does not mean you will develop pancreatic cancer, and many patients have none. If you are concerned, a focused assessment including imaging can provide clarity.

Accurate staging is the foundation of treatment planning. The key investigations are:

• CT pancreas protocol (triple-phase) — the primary staging scan; defines tumour size, vascular involvement, and distant spread
• Endoscopic ultrasound (EUS) with biopsy — when tissue diagnosis is needed before treatment
• MRCP — detailed mapping of bile duct and pancreatic duct involvement
• CA 19-9 tumour marker — useful for monitoring response to treatment; not reliable for diagnosis alone
• Staging and resectability assessment — the single most important question: can this tumour be removed with clear margins?
• Multidisciplinary tumour board (MDT) — Dr Kumar presents complex cases at MDT to ensure the treatment plan draws on surgical, oncological, and radiological expertise

• Whipple’s procedure (pancreaticoduodenectomy) — for tumours in the head of the pancreas or periampullary region; removes the head, duodenum, part of the bile duct, and gallbladder
• Distal pancreatectomy — for tumours in the body or tail; minimally-invasive (laparoscopic) approach is well-established and Dr Kumar uses it where oncologically appropriate
• Total pancreatectomy — when the tumour spans the gland or multifocal disease requires complete removal

• Neoadjuvant chemotherapy — for borderline-resectable tumours, chemotherapy can shrink the tumour to allow surgery; response is re-assessed with repeat imaging
• Adjuvant chemotherapy — after surgery, to reduce the risk of recurrence
• Palliative biliary stenting or surgical bypass — for advanced tumours causing jaundice or gastric outlet obstruction, to restore quality of life

Dr Ameet Kumar is a high-volume HPB and GI-oncology surgeon with M.Ch (GI Surgery) from AIIMS New Delhi and FRCS (Glasgow) — one of the most demanding qualifications in surgery. Over 25 years and 4,500+ operations, he has performed Whipple’s procedures, distal pancreatectomies, and complex vascular reconstructions for pancreatic cancer.

• Minimally-invasive where appropriate — laparoscopic distal pancreatectomy, laparoscopic staging, and minimally-invasive reconstruction are used when they serve the patient’s oncological interests
• Careful patient selection — not every patient with a pancreatic mass benefits from surgery; Dr Kumar will tell you honestly if observation, biopsy, or non-surgical treatment is the right path
• Honest counselling — you will receive a clear explanation of what the scans show, what surgery can and cannot achieve, and what the alternatives are
• MDT-planned care — complex cases are reviewed at tumour board before treatment begins

Pancreatic surgery is major surgery, and honest expectations matter:

• Hospital stay — typically 7–10 days after Whipple’s; 4–6 days after distal pancreatectomy
• Return to normal activity — most patients are back to light activity within 4–6 weeks; full recovery takes 3 months
• Pancreatic enzyme supplements — most patients require pancreatic enzyme replacement therapy (PERT) after surgery to aid digestion; tablets with meals
• Diabetes management — blood sugar is monitored carefully; some patients develop new-onset diabetes after pancreatectomy and will need insulin or medication
• Structured follow-up — regular CT scans, CA 19-9 monitoring, and oncology review to detect any recurrence early

Outcomes depend heavily on stage, margin status, and biology. Dr Kumar will discuss realistic expectations before any procedure — not after.

Not every pancreatic condition is cancer. Acute pancreatitis, chronic pancreatitis, and pancreatic cysts (including pseudocysts, serous cystadenoma, IPMN, and MCN) are all assessed and managed here. Many cysts are benign and need only surveillance; others warrant surgery to prevent malignant change. Dr Kumar will advise clearly which applies in your case.